Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company is headquartered in New York, New York.
Click "Analyze" to generate stock analysis
DCTH Price Trend and Signals
DCTH Option Volumes & Open Interests (aggregated)
DCTH Put Call Ratios and IV (aggregated)
DCTH Financials
2025-10-29Somewhat Bearishprice_signal
Half-yearly low detected.
2025-10-27Somewhat Bearishprice_signal
Half-yearly low detected.
2025-10-24Somewhat Bearishprice_signal
Monthly low detected.
2025-10-22Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-22Somewhat Bearishprice_signal
Monthly low detected.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-10-20Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-10-20Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-10-20Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-10-20Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.